Aptamer going public on LSE8 Dec 2021 18:36
Hoping that you are well?
Probably has been posted already but......
Aptamer Group PLC - Heslington, York-based life sciences firm which operates in custom services, diagnostics and therapeutics - Eyes listing on AIM segment of London Stock Exchange mid-December. Does not give any specifics of the planned listing.
Company focuses on aptamer discovery, services and in developing aptamer-based reagents. Aptamers are synthetic nucleic acid-based biological molecules, selected based on their specific characteristics to bind to a "target" of interest, such as proteins, cells, viruses or small molecules.
The ability to bind in a predictable, measurable and controllable way to such targets, creates opportunities in diagnostics, therapeutics, bioprocessing and research applications, company says.
"The target binding characteristics of aptamers means that they are often thought of as 'chemical antibodies' and positions them as a disruptive technology in the well-established global antibody market worth over USD145.7 billion per annum (2021) and expected to reach USD248.9 billion by 2026," company adds.